2 Patents
- US125995492026Treatment of Moderate to Very Severe Glabellar Lines and Lateral Canthal Lines
Galderma Holding SA
0 cites - US122854682025Liquid Neurotoxin Formulation Stabilized with Tryptophan or Tyrosine
IPSEN BIOPHARM LIMITED
0 cites
Galderma Holding SA
IPSEN BIOPHARM LIMITED